Literature DB >> 2859136

Triazolam and ethanol interaction: kinetic and dynamic consequences.

P Dorian, E M Sellers, H L Kaplan, C Hamilton, D J Greenblatt, D Abernethy.   

Abstract

The kinetic and dynamic consequences of the coadministration of triazolam and ethanol were investigated in six normal subjects. Each received three treatments: triazolam, 0.25 mg by mouth, preceded by 1 hour and followed for 7.5 hours by oral ethanol dosed to maintain breath concentrations of 800 to 950 mg/L; placebo and ethanol; and triazolam and orange juice. After ethanol, triazolam total AUC0-infinity increased (mean +/- SD = 21% +/- 18%). Subjects showed greater psychomotor impairment on measures of free recall, postural stability, and hand-eye coordination after the combination than after either drug alone. These dynamic interactions are greater than the kinetic changes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2859136     DOI: 10.1038/clpt.1985.88

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  10 in total

Review 1.  Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol).

Authors:  Lingtak-Neander Chan; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2014-12       Impact factor: 6.447

2.  Evaluation in rats of the somnogenic, pyrogenic, and central nervous system depressant effects of muramyl dipeptide.

Authors:  L T Meltzer; K A Serpa; W H Moos
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Comparison of the daytime sleep and performance effects of zolpidem versus triazolam.

Authors:  T J Balkin; V M O'Donnell; N Wesensten; U McCann; G Belenky
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 4.  Effects of ethanol on drug and metabolite pharmacokinetics.

Authors:  E A Lane; S Guthrie; M Linnoila
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

5.  Reinforcing effectiveness of midazolam, ethanol, and sucrose: behavioral economic comparison of a mixture relative to its component solutions.

Authors:  E Andrew Townsend; Donna M Platt; James K Rowlett; Peter G Roma; Kevin B Freeman
Journal:  Behav Pharmacol       Date:  2017-08       Impact factor: 2.293

Review 6.  Pharmacokinetics of the newer benzodiazepines.

Authors:  P D Garzone; P D Kroboth
Journal:  Clin Pharmacokinet       Date:  1989-06       Impact factor: 6.447

7.  Discriminating the effects of triazolam on stimulus and response processing by means of reaction time and P300 latency.

Authors:  E Pang; B Fowler
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

8.  The effect of a single oral dose of ethanol on hepatic blood flow in man.

Authors:  D J Edwards; L M Babiak; H B Beckman
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

9.  Pharmacological Interactions between the Dual Orexin Receptor Antagonist Daridorexant and Ethanol in a Double-Blind, Randomized, Placebo-Controlled, Double-Dummy, Four-Way Crossover Phase I Study in Healthy Subjects.

Authors:  Benjamin Berger; Sander Brooks; Rob Zuiker; Muriel Richard; Clemens Muehlan; Jasper Dingemanse
Journal:  CNS Drugs       Date:  2020-11-18       Impact factor: 5.749

Review 10.  Benzodiazepine poisoning. Clinical and pharmacological considerations and treatment.

Authors:  P Gaudreault; J Guay; R L Thivierge; I Verdy
Journal:  Drug Saf       Date:  1991 Jul-Aug       Impact factor: 5.606

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.